Unité de Fabrication de Médicaments (UMED)
Last update: 28 March 12:10 PM market time.
0.04
0.55%
Open
7.18
Previous Close
7.23
High
7.27
Low
7.18
Stock Statistics
Volume
7,412
Turnover
53,603.51
All data are 15 minutes late during market session
- Stock
- Company Profile
- News
- Announcements
- Fair Values
- Corporate Actions
- Earning Announcements
- News Reports
- Volume Statistics
- Financial Ratios
- IPOs
- Financial Statements
- Support and resistance
- More
General Information
Company Name
Unité de Fabrication de Médicaments (UMED)
Company Purpose
Unité de Fabrication de Médicaments (known as: UNIMED) is a private company operating within the pharmaceuticals, biotechnology & life sciences sector focusing on pharmaceuticals. UNIMED is based in Sousse, Tunisia and was established in Ocober 1989.
Company Establish Date
24 October 1989
Financial Year Start
Auditor
- Conseil d'Audit Formation
Ownership
- Ridha Charfeddine (70.00%)
- Premium Holding (40.77%)
- Consortium Tuniso-Koweitien de Développement (12.28%)
- SSB A/C SQM Frontier Africa Master Fund Ltd (6.84%)
- Pictet Europe - A/C Blakeney LP (5.94%)
- Slah Ben Turkia (3.51%)
- Assurances Multirisques Ittihad (2.00%)
- Blakeney Investors SICAV (1.31%)
- Blakeney Optima LP (1.30%)
- CCDP LP (0.48%)
Management
Ridha Charfeddine
Chairman
Lotfi Charfeddine
Board Members
Ines Jaafoura
Board Members
Salah Ben Turkia
Board Members
Habib Essayeh
Board Members
Mourad Razi
Board Members
Subsidiaries
- La Société Promochimica (17.51%)
Contacts
Address
BP 38, Industrial Zone Kalaa Kebira, Sousse 4060, Tunisia
Phone
+216 7 3342669
Fax
+ 216 7 3342472
Website
www.unimed.com.tn
Email
[email protected]
Contact Person
Lotfi Charfeddine